STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals
Reported by STAT News · all stories from statnews.com
Editorial digest
Medicare's financial incentives for artificial intelligence-powered devices hold significant implications for both technology firms and healthcare organizations. These policies shape adoption and innovation.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom8/13/2026
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices
An investigation examines Commure and Medicare's AI device incentives.
- Trusted health newsroom8/27/2026
STAT+: CMS plans launch event for ACCESS, the Medicare chronic care pilot
CMS is preparing an event for its new chronic care pilot, ACCESS.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom8/24/2026
STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
FDA digital health head confirms generative AI regulatory guidelines are in development.
- Reputable trade press8/20/2026
FDA considers ‘competency-based’ evaluations for GenAI-enabled medical devices - MassDevice
The FDA is considering 'competency-based' evaluations for generative AI medical devices.
- Trusted health newsroom8/14/2026
STAT+: Epic’s alleged anticompetitive practices under scrutiny from federal, state investigators
Epic's alleged anticompetitive actions are under federal and state investigation.